Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
ASND
Ascendis Pharma A/S ASND
$233.03
โ–ฒ +1.14% 24H
12.5471.17129.80188.42247.052015-012017-112020-102023-082026-06

About

Ascendis Pharma A/S is a biopharmaceutical company that develops and commercializes therapies for patients with unmet medical needs, with a primary focus on endocrinology and rare diseases. Headquartered in Hellerup, Denmark and founded in 2006, the company uses its TransCon technology platform to modify existing drug โ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryDenmark
Employees1,017
TickerASND

Statistics

Market Cap$14.40B
Revenue (TTM)$961.7M
Net Incomeโ€”
Net Marginโ€”
EPSโ€”
P/E24.06
P/S14.97
P/B23.15
EV/EBITDA-1306.16
ROE332.7%
Dividend Yieldโ€”
Price$233.03

Data: Twelve Data ยท Revenue = mcap / P/S

Ascendis Pharma A/S (ASND) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap